A prospective, randomized, single-blind, multicentre, phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in organ transplantation (kidney, liver and pancreas)

Organ preservation before transplantation is still a challenge. Both the University of Wisconsin and Bretschneider’s histidine-tryptophan-ketoglutarate (HTK; Custodiol®) solution are standard for liver, kidney and pancreas preservation. Organ preservation with both solutions is comparable; recently,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kniepeiss, Daniela (VerfasserIn) , Houben, Philipp (VerfasserIn) , Stiegler, Philipp (VerfasserIn) , Berghold, Andrea (VerfasserIn) , Riedl, Regina (VerfasserIn) , Kahn, Judith (VerfasserIn) , Schemmer, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [2020]
In: Trials
Year: 2020, Jahrgang: 21, Pages: 1-13
ISSN:1468-6694
DOI:10.1186/s13063-019-3823-4
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13063-019-3823-4
Volltext
Verfasserangaben:Daniela Kniepeiss, Philipp Houben, Philipp Stiegler, Andrea Berghold, Regina Riedl, Judith Kahn and Peter Schemmer
Beschreibung
Zusammenfassung:Organ preservation before transplantation is still a challenge. Both the University of Wisconsin and Bretschneider’s histidine-tryptophan-ketoglutarate (HTK; Custodiol®) solution are standard for liver, kidney and pancreas preservation. Organ preservation with both solutions is comparable; recently, however, Custodiol® solution has been modified to Custodiol-N according to the needs of today. Thus, our study was defined to study its effect in clinical transplantation.
Beschreibung:Gesehen am 26.03.2020
Beschreibung:Online Resource
ISSN:1468-6694
DOI:10.1186/s13063-019-3823-4